Literature DB >> 31670928

Predictors of Parenchymal Hematoma After Mechanical Thrombectomy: A Multicenter Study

William Boisseau1, Robert Fahed1, Bertrand Lapergue2, Jean-Philippe Desilles1,3,4, Kevin Zuber1, Naim Khoury5, Jeanne Garcia2, Benjamin Maïer1, Hocine Redjem1, Gabriele Ciccio1, Stanislas Smajda1, Simon Escalard1, Guillaume Taylor6, Mikael Mazighi1,3,4, Piotin Michel1,3,4, Benjamin Gory7,8, Raphaël Blanc1,3,4.   

Abstract

Background and Purpose: Parenchymal hematoma (PH) is a rare but dreadful complication of acute ischemic stroke with unclear underlying mechanisms. We aimed to study the incidence and predictors of PH after mechanical thrombectomy.
Methods: Data from a prospective observational multicenter registry was screened to identify acute ischemic stroke patients with an anterior circulation large vessel occlusion who underwent mechanical thrombectomy. Clinical, imaging, and procedural characteristics were used for the analysis, including brain imaging systematically performed at 24 hours. PH occurrence was assessed according to ECASS (European Collaborative Acute Stroke Study) criteria. Univariate and multivariable analyses were performed to identify predictors of PH.
Results: A total of 1316 patients were included in the study. PH occurred in 153 out of 1316 patients (11.6%) and was associated with a lower rate of favorable outcome and increased mortality. On multivariable analysis, age (per 1 year increase, odds ratio [OR], 1.01; 95% CI, 1.00–1.03; P=0.05), current smoking (OR, 2.02; 95% CI, 1.32–3.09; P<0.01), admission Alberta Stroke Program Early CT Score (per a decrease of 1 point, OR, 1.70; 95% CI, 1.18–2.44; P<0.01), general anesthesia (OR, 1.98; 95% CI, 1.36–2.90; P<0.001), angiographic poor collaterals (OR, 2.13; 95% CI, 1.36–3.33; P<0.001) and embolization in new territory (OR, 2.94; 95% CI, 1.70–5.10; P<0.001) were identified as independent predictors of PH. Conclusions: PH occurred at a rate of 11.6% after mechanical thrombectomy, with high morbidity and mortality. Our study identified clinical, radiological, and procedural predictors of PH occurrence that can serve as the focus of future periprocedural management studies with the aim of reducing its occurrence.
© 2019 American Heart Association, Inc.

Entities:  

Keywords:  brain; hematoma; incidence; intracranial hemorrhage; thrombectomy

Mesh:

Year:  2019        PMID: 31670928     DOI: 10.1161/STROKEAHA.118.024512

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Endovascular Treatment After Stroke Due to Large Vessel Occlusion for Patients Presenting Very Late From Time Last Known Well.

Authors:  Beom Joon Kim; Bijoy K Menon; Jun Yup Kim; Dong-Woo Shin; Sung Hyun Baik; Cheolkyu Jung; Moon-Ku Han; Andrew Demchuk; Hee-Joon Bae
Journal:  JAMA Neurol       Date:  2020-08-10       Impact factor: 18.302

2.  Safety and Efficacy of Cangrelor in Acute Stroke Treated with Mechanical Thrombectomy: Endovascular Treatment of Ischemic Stroke Registry and Meta-analysis.

Authors:  G Marnat; S Finistis; F Delvoye; I Sibon; J-P Desilles; M Mazighi; F Gariel; A Consoli; C Rosso; F Clarençon; M Elhorany; C Denier; V Chalumeau; J Caroff; L Veunac; F Bourdain; J Darcourt; J-M Olivot; R Bourcier; C Dargazanli; C Arquizan; S Richard; B Lapergue; B Gory
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-03       Impact factor: 3.825

3.  ESO guideline for the management of extracranial and intracranial artery dissection.

Authors:  Stephanie Debette; Mikael Mazighi; Philippe Bijlenga; Alessandro Pezzini; Masatoshi Koga; Anna Bersano; Janika Kõrv; Julien Haemmerli; Isabella Canavero; Piotr Tekiela; Kaori Miwa; David J Seiffge; Sabrina Schilling; Avtar Lal; Marcel Arnold; Hugh S Markus; Stefan T Engelter; Jennifer J Majersik
Journal:  Eur Stroke J       Date:  2021-10-13

4.  CTA-Based Patient-Tailored Femoral or Radial Frontline Access Reduces the Rate of Catheterization Failure in Chronic Subdural Hematoma Embolization.

Authors:  E Shotar; G Pouliquen; K Premat; A Pouvelle; S Mouyal; L Meyblum; S Lenck; V Degos; S Abi Jaoude; N Sourour; B Mathon; F Clarençon
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-04       Impact factor: 3.825

Review 5.  Pathophysiology of Blood-Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery.

Authors:  Sara Bernardo-Castro; João André Sousa; Ana Brás; Carla Cecília; Bruno Rodrigues; Luciano Almendra; Cristina Machado; Gustavo Santo; Fernando Silva; Lino Ferreira; Isabel Santana; João Sargento-Freitas
Journal:  Front Neurol       Date:  2020-12-09       Impact factor: 4.003

6.  Is This Contrast? Is This Blood? An Agreement Study on Post-thrombectomy Computed Tomography Scans.

Authors:  Ronda Lun; Gregory B Walker; Adrien Guenego; Mohammed Kassab; Eduardo Portela; Vignan Yogendrakumar; George Medvedev; Ken Wong; Michel Shamy; Dar Dowlatshahi; Robert Fahed
Journal:  Front Neurol       Date:  2020-12-22       Impact factor: 4.003

Review 7.  Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients.

Authors:  Benjamin Maïer; Jean Philippe Desilles; Mikael Mazighi
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

8.  Types of intraparenchymal hematoma as a predictor after revascularization in patients with anterior circulation acute ischemic stroke.

Authors:  Yusuke Morinaga; Kouhei Nii; Yusuke Takemura; Hayatsura Hanada; Kimiya Sakamoto; Yoko Hirata; Ritsurou Inoue; Jun Tsugawa; Satoshi Kimura; Kanako Kurihara; Yuji Tateishi; Toshio Higashi
Journal:  Surg Neurol Int       Date:  2021-03-17

9.  Predicting hemorrhagic transformation after large vessel occlusion stroke in the era of mechanical thrombectomy.

Authors:  Takanori Iwamoto; Takaya Kitano; Naoki Oyama; Yoshiki Yagita
Journal:  PLoS One       Date:  2021-08-16       Impact factor: 3.240

Review 10.  Imaging in Acute Anterior Circulation Ischemic Stroke: Current and Future.

Authors:  Hyun Jeong Kim; Hong Gee Roh
Journal:  Neurointervention       Date:  2022-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.